Page 75 - ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் சுற்றுச்சூழல் மாற்றம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் சுற்றுச்சூழல் மாற்றம் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் சுற்றுச்சூழல் மாற்றம் நிறுவனம் Today - Breaking & Trending Today

Typo in UConn's student newspaper gives readers a giggle, break from bleak pandemic news


Typo in UConn s student newspaper gives readers a giggle, break from bleak pandemic news
Martha Shanahan
FacebookTwitterEmail
The front page of the Daily Campus, UConn s student newspaper, on Friday, February 19, 2021.Contributed by Grace McFadden
There are certain things that just happen in the offices of a daily college newspaper. Pizza stains on newsprint. Fights over Oxford commas. All-nighters.
And, inevitably, typos.
An editor of UConn’s student newspaper learned the hard way last week just how easy it is to change the whole meaning of a story with a slip of the mouse. She inadvertently implied on the front page that some UConn students were happy to get COVID. ....

United States , Daily Campu , Hartford Courant , Grace Mcfadden , Daily Campus , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் , தினசரி காம்பு , ஹார்ட்ஃபோர்ட் கூரண்ட் , கருணை மக்ஃப்யாடந் , தினசரி வளாகம் ,

Evox has big pharma partners. Now it has $95M to bring its own drugs to the clinic


MedCity News
Evox has big pharma partners. Now it has $95M to bring its own drugs to the clinic
In the past year, Evox Therapeutics has inked alliances with two big pharma companies. The Series C financing now positions the biotech to advance to the clinic with its own exosome-based therapies.
Shares0
 
Cells in the body share material via tiny vesicles that shuttle between them, carrying molecular payloads from one cell to another. Evox Therapeutics is developing medicines that leverage this mechanism as way of accessing cells and tissues that are beyond the reach of current drug technologies.
The biotech has research partnerships with two large pharmaceutical companies. Now it has $95.4 million to advance into clinical testing with several rare disease drug candidates. Redmile Group led the Series C round of funding. ....

United Kingdom , Red Mile , Chau Khuong , Codiak Biosciences , Eli Lilly , Oxford Sciences Innovation , Karolinska Institute , Redmile Group , Oxford University , United Kingdom Based Evox , Takeda Pharmaceutical , Massachusetts Based Codiak Biosciences , Cowen Healthcare , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Motion Sensors , Healthcare It , Foodborne Pathogens ,